AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
263.29
-2.99 (-1.12%)
At close: Sep 29, 2026, 4:00 PM EDT
264.10
+0.81 (0.31%)
Pre-market: Sep 30, 2026, 8:46 AM EDT

AbbVie Stock Forecast

Stock Price Forecast

According to 30 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $278.61. The average 1-year stock price forecast is 5.82% higher than the current stock price, while the lowest is $200 (-24.04%) and the highest is $328 (+24.58%).

Price Target: $278.61 (+5.82%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$200$278.61$283.5$328
Change-24.04%+5.82%+7.68%+24.58%

Analyst Ratings

The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy161616161716
Buy888888
Hold886655
Sell001111
Strong Sell000000
Total323231313130

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$290
BuyReiterates$290+10.14%Sep 29, 2026
BMO Capital
BMO Capital
Buy
Reiterates
$300
BuyReiterates$300+13.94%Sep 29, 2026
Citi
Citi
Hold
Maintains
$260
HoldMaintains$260-1.25%Sep 29, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$282 → $289
BuyReiterates$282 → $289+9.76%Sep 29, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aSep 28, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
67.60B
from 61.16B
Increased by 10.53%
Revenue Next Year
73.50B
from 67.60B
Increased by 8.72%
EPS This Year
14.01
from 10.00
Increased by 40.07%
EPS Next Year
16.26
from 14.01
Increased by 16.07%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
56.20B58.05B54.32B56.33B61.16B67.60B
Revenue Growth
22.69%3.30%-6.44%3.71%8.57%10.53%
Operating Income
19.76B20.23B18.21B17.42B21.12B31.38B
Net Income
11.54B11.84B4.86B4.28B4.23B14.07B
EPS
----10.0014.01
EPS Growth
-----1.19%40.07%
Forward PE
10.0412.7213.9614.8116.5718.80
Dividend / Share
5.315.715.996.296.656.93
Dividend Growth
9.71%7.53%4.90%5.01%5.72%4.27%
Free Cash Flow
----17.82B24.79B
No. Analysts
-----23
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High67.8B
Avg67.6B
Low67.1B

Revenue Growth

Revenue Growth202620272028
High
10.8%
Avg
10.5%
Low
9.7%

EPS Forecast

EPS202620272028
High14.12
Avg14.01
Low13.90

EPS Growth

EPS Growth202620272028
High
41.2%
Avg
40.1%
Low
39.0%